Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Shanghai Jiao Tong University School of Medicine

Status: Completed

Conditions: Hypertension, Resistant to Conventional Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT01459042

19830409

Details and patient eligibility

About

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with resistant hypertension
• age 18-65 years

Exclusion criteria

• known cause of hypertension
• heart failure
• renal dysfunction
• Stroke, transient ischaemic attack or myocardial infarction in the past 6 months
• cirrhosis
• pregnancy
• undertreatment of glucocorticoid

Trial design

2,000 participants in 2 patient groups

primary aldosteronism

essential hypertension